: Dr. Martin-Schild graduated from the Tulane University School of Medicine, while also obtaining her PhD in Neuroscience. Dr. Martin-Schild completed a combined internal medicine and neurology residency at Tulane University School of Medicine, followed by fellowship training in Vascular Neurology and clinical research in Vascular Neurology at the University of Texas Health Science Center in Houston, Texas. Dr. Martin-Schild founded and directed the Stroke Program at Tulane Medical Center 2008-2016. She advanced Tulane Medical Center to Primary Stroke Center level in less than 2 years from inception and Comprehensive Stroke Center 3 years later. Her service delivered the highest rate of and most efficient with thrombolytic treatment for ischemic stroke in Louisiana. Dr. Martin-Schild serves as the Statewide Stroke Medical Director for the Louisiana Emergency Response Network. She is the President & CEO of Dr. Brain, Inc., which provides on-site stroke leadership and patient care to hospitals committed to improving or developing stroke programs. She currently serves as the Medical Director of Neurology & Stroke for the New Orleans East Hospital and Touro Infirmary. Dr. Martin-Schild’s research focuses on access to stroke care, racial disparities in outcome, and augmentation of rehab potential with neurostimulants. She has more than 100 manuscripts published in peer-reviewed journals. On behalf of Genentech, a nationwide Stroke Awareness Survey was conducted on March 25 – April 10, 2020 among 2,009 adults ages 35+ in the U.S. BE FAST was developed by Intermountain Healthcare, as an adaptation of the FAST model implemented by the American Stroke Association. Reproduced with permission from Intermountain Healthcare. © 2011 Intermountain Healthcare. All rights reserved. Support for this campaign is provided by Genentech Inc., a member of the Roche Group. © 2020 Genentech USA, Inc. All rights reserved